Puneet Souda
Stock Analyst at Leerink Partners
(1.93)
# 3,035
Out of 4,761 analysts
211
Total ratings
45.66%
Success rate
-0.93%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $64.49 | +16.30% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $14.18 | +48.10% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $2.53 | +58.10% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $39.18 | +2.09% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $162.31 | -7.58% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $374.82 | +0.05% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $6.22 | +60.77% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $532.55 | +18.30% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $25.75 | +35.92% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $135.37 | +7.11% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $210.23 | +42.70% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $94.20 | +165.39% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $64.92 | +69.44% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $49.26 | +52.25% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $158.99 | +25.79% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $3.03 | +494.06% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $3.65 | +64.38% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $41.31 | -27.38% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $7.55 | +98.68% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $11.10 | +35.14% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $50.82 | +71.19% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $42.87 | +226.57% | 5 | Feb 24, 2022 |
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $64.49
Upside: +16.30%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $14.18
Upside: +48.10%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $2.53
Upside: +58.10%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $39.18
Upside: +2.09%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $162.31
Upside: -7.58%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $374.82
Upside: +0.05%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $6.22
Upside: +60.77%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $532.55
Upside: +18.30%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $25.75
Upside: +35.92%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $135.37
Upside: +7.11%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $210.23
Upside: +42.70%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $94.20
Upside: +165.39%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $64.92
Upside: +69.44%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $49.26
Upside: +52.25%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $158.99
Upside: +25.79%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $3.03
Upside: +494.06%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $3.65
Upside: +64.38%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $41.31
Upside: -27.38%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $7.55
Upside: +98.68%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $11.10
Upside: +35.14%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $50.82
Upside: +71.19%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $42.87
Upside: +226.57%